Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caloric Restriction | 9 | 2021 | 73 | 2.860 |
Why?
|
| DNA Methylation | 7 | 2018 | 153 | 2.250 |
Why?
|
| Aging | 10 | 2021 | 976 | 1.690 |
Why?
|
| Longevity | 5 | 2021 | 134 | 1.630 |
Why?
|
| Homeostasis | 2 | 2021 | 117 | 1.230 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 633 | 0.840 |
Why?
|
| Diet Therapy | 1 | 2021 | 9 | 0.750 |
Why?
|
| Litter Size | 1 | 2021 | 12 | 0.740 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2021 | 82 | 0.740 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 61 | 0.730 |
Why?
|
| Animals | 24 | 2021 | 10416 | 0.720 |
Why?
|
| Genotype | 2 | 2021 | 457 | 0.700 |
Why?
|
| Folic Acid Deficiency | 4 | 2021 | 5 | 0.670 |
Why?
|
| Mice | 16 | 2021 | 4655 | 0.650 |
Why?
|
| Epigenomics | 3 | 2018 | 29 | 0.640 |
Why?
|
| Sirolimus | 1 | 2020 | 76 | 0.620 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 123 | 0.620 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 147 | 0.610 |
Why?
|
| Oxidative Stress | 5 | 2016 | 663 | 0.600 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 49 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 1573 | 0.570 |
Why?
|
| Genomics | 1 | 2018 | 123 | 0.540 |
Why?
|
| Obesity | 2 | 2018 | 668 | 0.470 |
Why?
|
| Folic Acid | 3 | 2021 | 32 | 0.450 |
Why?
|
| DNA Polymerase beta | 2 | 2010 | 3 | 0.440 |
Why?
|
| DNA Damage | 5 | 2016 | 149 | 0.430 |
Why?
|
| Liver | 4 | 2021 | 441 | 0.390 |
Why?
|
| Male | 15 | 2021 | 13510 | 0.320 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2009 | 3 | 0.310 |
Why?
|
| Diet | 3 | 2021 | 232 | 0.310 |
Why?
|
| DNA Repair | 5 | 2021 | 83 | 0.290 |
Why?
|
| Body Composition | 2 | 2021 | 265 | 0.290 |
Why?
|
| Carrier Proteins | 1 | 2009 | 252 | 0.270 |
Why?
|
| Models, Animal | 2 | 2018 | 128 | 0.270 |
Why?
|
| Hippocampus | 2 | 2018 | 189 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 345 | 0.200 |
Why?
|
| Apoptosis | 3 | 2018 | 774 | 0.190 |
Why?
|
| Weaning | 1 | 2021 | 18 | 0.190 |
Why?
|
| Mice, Inbred Strains | 1 | 2021 | 61 | 0.190 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 60 | 0.180 |
Why?
|
| Rats | 4 | 2020 | 1568 | 0.180 |
Why?
|
| Carcinogenesis | 1 | 2021 | 84 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 194 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2021 | 1433 | 0.180 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 27 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 139 | 0.160 |
Why?
|
| Estradiol | 1 | 2020 | 175 | 0.160 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 521 | 0.160 |
Why?
|
| Female | 6 | 2021 | 15191 | 0.160 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 197 | 0.160 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 29 | 0.140 |
Why?
|
| Neuroprotection | 1 | 2018 | 14 | 0.140 |
Why?
|
| Necrosis | 1 | 2018 | 84 | 0.140 |
Why?
|
| Enzymes | 1 | 2018 | 23 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 133 | 0.140 |
Why?
|
| Epididymis | 1 | 2017 | 5 | 0.140 |
Why?
|
| Pregnancy | 1 | 2021 | 1191 | 0.140 |
Why?
|
| Fish Oils | 1 | 2017 | 12 | 0.140 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 16 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 110 | 0.140 |
Why?
|
| Food | 1 | 2017 | 33 | 0.130 |
Why?
|
| Humans | 7 | 2020 | 28166 | 0.130 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 48 | 0.130 |
Why?
|
| Inflammation | 2 | 2018 | 633 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 43 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2018 | 311 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2018 | 398 | 0.130 |
Why?
|
| Life Expectancy | 1 | 2015 | 23 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2016 | 125 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2016 | 194 | 0.120 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2014 | 1 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 44 | 0.110 |
Why?
|
| Mitochondria | 1 | 2017 | 366 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2014 | 96 | 0.110 |
Why?
|
| Drosophila | 1 | 2012 | 32 | 0.100 |
Why?
|
| Curcumin | 1 | 2012 | 69 | 0.090 |
Why?
|
| DNA Footprinting | 1 | 2010 | 5 | 0.090 |
Why?
|
| Deoxyguanosine | 1 | 2010 | 14 | 0.090 |
Why?
|
| CpG Islands | 1 | 2010 | 27 | 0.090 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2010 | 28 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 50 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2010 | 138 | 0.080 |
Why?
|
| Base Sequence | 1 | 2010 | 585 | 0.080 |
Why?
|
| Nitroparaffins | 1 | 2009 | 1 | 0.080 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2009 | 1 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 131 | 0.080 |
Why?
|
| Propane | 1 | 2009 | 3 | 0.080 |
Why?
|
| DNA Glycosylases | 1 | 2009 | 2 | 0.080 |
Why?
|
| Protein Stability | 1 | 2009 | 43 | 0.080 |
Why?
|
| Caspases | 1 | 2009 | 42 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1052 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 122 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2009 | 267 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 103 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2009 | 191 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2010 | 985 | 0.070 |
Why?
|
| Genomic Instability | 1 | 2007 | 34 | 0.070 |
Why?
|
| Insulin Resistance | 2 | 2020 | 176 | 0.070 |
Why?
|
| Protein Binding | 1 | 2009 | 657 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 281 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2020 | 847 | 0.060 |
Why?
|
| Cushing Syndrome | 1 | 2005 | 4 | 0.060 |
Why?
|
| Age Factors | 2 | 2018 | 733 | 0.050 |
Why?
|
| Body Weight | 2 | 2015 | 252 | 0.050 |
Why?
|
| Sulfathiazoles | 1 | 2021 | 1 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2020 | 29 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2018 | 8 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2018 | 22 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2018 | 22 | 0.040 |
Why?
|
| Memory | 1 | 2018 | 73 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 40 | 0.040 |
Why?
|
| Time Factors | 1 | 2021 | 1593 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 25 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 523 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 67 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 26 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 172 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 369 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 416 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 137 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 133 | 0.030 |
Why?
|
| Cause of Death | 1 | 2015 | 73 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2017 | 206 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 363 | 0.030 |
Why?
|
| Kidney | 1 | 2016 | 286 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 62 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 137 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2014 | 107 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 763 | 0.030 |
Why?
|
| Motor Activity | 1 | 2014 | 147 | 0.030 |
Why?
|
| Larva | 1 | 2012 | 28 | 0.020 |
Why?
|
| Locomotion | 1 | 2012 | 22 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2021 | 0.020 |
Why?
|
| Reproduction | 1 | 2012 | 63 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 122 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2012 | 102 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 545 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 608 | 0.020 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 2010 | 3 | 0.020 |
Why?
|
| Animal Feed | 1 | 2010 | 20 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 679 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 7765 | 0.020 |
Why?
|
| Vitamins | 1 | 2010 | 23 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 2738 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 3128 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 192 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 509 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 634 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 5416 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 7164 | 0.020 |
Why?
|
| Pigmentation Disorders | 1 | 2005 | 8 | 0.010 |
Why?
|
| Back Pain | 1 | 2005 | 20 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 215 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 477 | 0.010 |
Why?
|
| Hypertension | 1 | 2005 | 309 | 0.010 |
Why?
|